Frank MD - Apexigen Chief Officer

APGNDelisted Stock  USD 0.43  0.01  2.27%   

Insider

Frank MD is Chief Officer of Apexigen
Age 62
Phone650-931-6236
Webhttps://www.apexigen.com

Apexigen Management Efficiency

The company has return on total asset (ROA) of (0.894) % which means that it has lost $0.894 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (15.9805) %, meaning that it created substantial loss on money invested by shareholders. Apexigen's management efficiency ratios could be used to measure how well Apexigen manages its routine affairs as well as how well it operates its assets and liabilities.
Apexigen currently holds 106 K in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Apexigen has a current ratio of 1.22, suggesting that it is in a questionable position to pay out its financial obligations when due. Note, when we think about Apexigen's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

DSc MSEImmix Biopharma
75
Peter FacchiniEnveric Biosciences
60
Nandan BSImmix Biopharma
62
Mary DiBiaseX4 Pharmaceuticals
63
JD MBAImmix Biopharma
N/A
Gabriel BAImmix Biopharma
37
Joseph TuckerEnveric Biosciences
55
Richard MDX4 Pharmaceuticals
61
MBA IVEnveric Biosciences
68
Walter NewmanLeap Therapeutics
78
Ibrahim MDEnveric Biosciences
55
Keith MDX4 Pharmaceuticals
53
Dr MedScPhio Pharmaceuticals Corp
68
MBA MDImmix Biopharma
49
Augustine LawlorLeap Therapeutics
67
Renato SkerljX4 Pharmaceuticals
N/A
Avani KanubaddiEnveric Biosciences
51
Mark OMahonyLeap Therapeutics
53
Cynthia SirardLeap Therapeutics
54
Murray MDX4 Pharmaceuticals
63
Arthur TaverasX4 Pharmaceuticals
60
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. The company was founded in 2010 and is based in San Carlos, California. Apexigen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people. Apexigen (APGN) is traded on NASDAQ Exchange in USA and employs 11 people.

Management Performance

Apexigen Leadership Team

Elected by the shareholders, the Apexigen's board of directors comprises two types of representatives: Apexigen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apexigen. The board's role is to monitor Apexigen's management team and ensure that shareholders' interests are well served. Apexigen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apexigen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Xiaodong MD, CEO Pres
Francis Sarena, Chief Officer
Frank MD, Chief Officer
William Duke, Chief Officer
Jason Wright, VP CMC
Amy Wong, Sr Operations

Apexigen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Apexigen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Apexigen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Apexigen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apexigen will appreciate offsetting losses from the drop in the long position's value.

Moving against Apexigen Stock

  0.46MSFT Microsoft Aggressive PushPairCorr
  0.32PTAIY Astra International TbkPairCorr
The ability to find closely correlated positions to Apexigen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Apexigen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Apexigen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Apexigen to buy it.
The correlation of Apexigen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Apexigen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Apexigen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Apexigen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Apexigen Stock

If you are still planning to invest in Apexigen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apexigen's history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments